bioRN C-Level Circle: The Talent Advantage – hosted by PROGEN

bioRN C-Level Circle: The Talent Advantage – hosted by PROGEN

The bioRN C-Level Circle is the networking format exclusively for CEOs, CFOs, CSOs, CMOs and Executives from global enterprises and a space for trusting exchange, peer coaching and strategic discussions. Each event is
dedicated to a current hot topic with direct relevance for decision-makers in the life science industry.  Beyond the impulses, the evening is designed to foster meaningful peer-to-peer exchange among Life Science executives in a trusted and confidential setting. Together, we want to discuss common challenges, identify opportunities for collaboration and strengthen the leadership community of our region.

The next bioRN C-Level Circle is hosted by PROGEN.

Topic:

The Talent Advantage –How people become a company’s greatest competitive advantage.

Preliminary Agenda:

5:45: Registration and Welcome

6pm – 7:30: Impuls Talks

  • Beyond Salary: What attracts talent today –  Katja Betts, CEO at PROGEN
  • Retention: Why excellent employees stay with the company? Vojo ?
  • Growth starts with people: Why companies can only grow as fast as their ability to attract and develop the right people. 

7:30 – 9 pm – Networking with delicious drinks and food *

*Cost: approx. €30 per person. A selection of food and drinks will be offered at cost price. 

We are looking forward to meet you there!

Please note that every registration will be checked and confirmed promptly.

register now

Our latest News

discover more
The EU is providing nearly eight million euros in funding for two collaborative projects led by Heidelberg

The EU is providing nearly eight million euros in funding for two collaborative projects led by Heidelberg

From AI-assisted brain tumor diagnostics to training a new generation of interdisciplinary specialists: Two European collaborative projects are set to advance the diagnostics of tomorrow. They are being coordinated by Professor Dr. Dr. Felix Sahm of the Heidelberg Medical Faculty at Heidelberg University and the Department of Neuropathology at Heidelberg University Hospital. The European Union […]

Two ERC Starting Grants for Scientists at Universität Heidelberg

Two ERC Starting Grants for Scientists at Universität Heidelberg

European Research Council funds groundbreaking projects in paleoclimatology and cancer neuroscience The European Research Council (ERC) is awarding two valuable grants for early career researchers – two ERC Starting Grants – to Heidelberg University. One of them, worth 1.5 million euros, goes to PD Dr. Sophie Warken, who does her research at the Institutes of […]

Three nationwide research projects in the Network of University Medicine under Heidelberg leadership start the next funding phase

Three nationwide research projects in the Network of University Medicine under Heidelberg leadership start the next funding phase

With RACOON-LCS, PENGUIN and CanTEN, Heidelberg University’s Faculty of Medicine is leading projects on lung cancer screening, penicillin allergy and fungal infections within the Network of University Medicine (NUM), together with one other coordinating university for each project. Researchers at the Heidelberg Faculty of Medicine at Heidelberg University are jointly leading three newly launched nationwide […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp